GLOBUS MEDICAL INCGMEDEarnings & Financial Report
NYSE · health technology
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
NextMar 13, 2026
GMED Q3 2025 Key Financial Metrics
Revenue
$769.0M
Gross Profit
$516.5M
Operating Profit
$137.4M
Net Profit
$119.0M
Gross Margin
67.2%
Operating Margin
17.9%
Net Margin
15.5%
YoY Growth
22.9%
EPS
$0.88
Financial Flow
GLOBUS MEDICAL INC Q3 2025 Financial Summary
GLOBUS MEDICAL INC reported revenue of $769.0M for Q3 2025, with a net profit of $119.0M (15.5% margin). Cost of goods sold was $252.5M, operating expenses totaled $379.2M.
Key Financial Metrics
| Total Revenue | $769.0M |
|---|---|
| Net Profit | $119.0M |
| Gross Margin | 67.2% |
| Operating Margin | 17.9% |
| Report Period | Q3 2025 |
GLOBUS MEDICAL INC Annual Revenue by Year
GLOBUS MEDICAL INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.5B).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.5B |
| 2023 | $1.6B |
| 2022 | $1.0B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $616.5M | $606.7M | $629.7M | $625.7M | $657.3M | $598.1M | $745.3M | $769.0M |
| YoY Growth | 124.6% | 119.3% | 115.9% | 63.1% | 6.6% | -1.4% | 18.4% | 22.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.09B | $4.94B | $4.99B | $5.09B | $5.25B | $4.71B | $4.96B | $5.10B |
| Liabilities | $1.09B | $1.02B | $1.02B | $1.02B | $1.07B | $623.1M | $665.4M | $696.8M |
| Equity | $4.00B | $3.92B | $3.98B | $4.07B | $4.18B | $4.09B | $4.30B | $4.40B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $104.7M | $52.4M | $54.3M | $203.7M | $210.3M | $177.3M | $77.9M | $249.7M |
